Background

• Dokter yang sudah berpengalaman lebih dari 13 tahun di bidangnya.
• Lulusan training dari Guy’s and St Thomas’ NHS Foundation Trust, UK.
• Keahlian khusus pada head and neck cancers, lung cancers and general radiation oncology, stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT) or stereotactic ablative body radiotherapy (SABR), image-guided radiotherapy (IGRT), intensity modulated radiotherapy (IMRT), 3D conformal radiotherapy (3DCRT) and brachytherapy

• Dr Ivan Tham has been a specialist since 2006 and has experience with a variety of treatment techniques. These include stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT) or stereotactic ablative body radiotherapy (SABR), image-guided radiotherapy (IGRT), intensity modulated radiotherapy (IMRT), 3D conformal radiotherapy (3DCRT) and brachytherapy.
• Dr Tham was the head of department and senior consultant at the National University Hospital and Tan Tock Seng Hospital, as well as an associate professor at the National University of Singapore.
• He received training in clinical and radiation oncology at the National Cancer Centre in Singapore and Guy’s and St Thomas’ NHS Foundation Trust, UK.
• He currently serves in the Residency Advisory Committee (Radiation Oncology). He was also engaged in various other committees in the Ministry of Health, such as the Proton Beam Therapy Advisory committee and a National Advisory Committee on Cancer subcommittee.
• He also served as vice president of the Federation of Asian Organizations for Radiation Oncology from 2017 – 2018.
• Dr Tham has an active interest in clinical research in cancer, and has co-authored more than 60 peer-reviewed articles on clinical oncology, radiation oncology and imaging. His articles have been cited by other scientists more than 1,500 times.
• He has been involved in teaching both locally and overseas, and has given lectures in Singapore, Malaysia, Indonesia, Taiwan, Vietnam and Japan. He has also contributed to more than 5 textbook chapters in oncology.